The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection

Covolo, L; Bibert, Stéphanie; Donato, F; Bochud, Pierre-Yves; Lagging, M; Negro, Francesco; Fattovich, Giovanna

doi:10.1111/apt.12568

Scientific article

English

The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection

ContributorsCovolo, L; Bibert, Stéphanie; Donato, F; Bochud, Pierre-Yves; Lagging, M; Negro, Francesco; Fattovich, Giovanna

Published inAlimentary pharmacology & therapeutics, vol. 39, no. 3, p. 322-330

Publication date2014

Abstract

A novel dinucleotide variant TT/∆G (ss469415590) has been associated with hepatitis C virus clearance.

Affiliation

Research group

Etudes et traitement de l'hépatite C et B (554)

Citation (ISO format)

COVOLO, L et al. The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection. In: Alimentary pharmacology & therapeutics, 2014, vol. 39, n° 3, p. 322–330. doi: 10.1111/apt.12568

Article (Accepted version)

Identifiers

PID : unige:33503
DOI : 10.1111/apt.12568
PMID : 24308755

ISSN of the journal0269-2813

541views

0downloads

Creation01/20/2014 11:31:00 AM

First validation01/20/2014 11:31:00 AM

Update time03/14/2023 8:52:35 PM

Status update03/14/2023 8:52:35 PM

Last indexation01/16/2024 8:58:16 AM

Archive ouverte UNIGE

The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection

A novel dinucleotide variant TT/∆G (ss469415590) has been associated with hepatitis C virus clearance.

Technical informations